MYD88 and diffuse large B-cell lymphoma: Thirty percent of ABC-DLBCLs (>50% of MCD/C5-DLBCL) carry mutations of MYD88, among which a hotspot L265P substitution within the protein TIR (Toll/IL1 receptor) domain is selectively enriched in MCD-DLBCL [15,81].